Announcements

For the National Immunization Awareness Month, last August, we shared some high-quality and innovative research findings published in Cancers (ISSN: 2072-6694), which received extensive attention from scholars in this field.

This August, we would continue to share some of the outstanding studies related to cancer immunization published in 2022 and 2023, which are avaliable to read for free.

The list of relevant papers can be seen below:

“Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies”
by Long-Bin Jeng, Li-Ying Liao, Fu-Ying Shih and Chiao-Fang Teng
Cancers 2022, 14(18), 4380; https://doi.org/10.3390/cancers14184380
Available online: https://www.mdpi.com/2072-6694/14/18/4380

“Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy”
by Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Shinji Morisaki, Yusuke Nakamura and Hideya Onishi
Cancers 2022, 14(10), 2438; https://doi.org/10.3390/cancers14102438
Available online: https://www.mdpi.com/2072-6694/14/10/2438

“Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review”
by Xingliang Fang, Huanrong Lan, Ketao Jin, Daojun Gong and Jun Qian
Cancers 2022, 14(16), 3842; https://doi.org/10.3390/cancers14163842
Available online: https://www.mdpi.com/2072-6694/14/16/3842

“Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study”
by Ainhoa Hernandez, Marc Boigues, Eudald Felip, Marc Cucurull, Lucia Notario, Anna Pous, Pere Torres, Marta Benitez, Marina Rodriguez, Bibiana Quirant et al.
Cancers 2023, 15(1), 137; https://doi.org/10.3390/cancers15010137
Available online: https://www.mdpi.com/2072-6694/15/1/137

“Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8⁺ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma”
by Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li et al.
Cancers 2022, 14(18), 4512; https://doi.org/10.3390/cancers14184512
Available online: https://www.mdpi.com/2072-6694/14/18/4512

“Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study”
by Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva and Mikalai Katsin
Cancers 2022, 14(14), 3298; https://doi.org/10.3390/cancers14143298
Available online: https://www.mdpi.com/2072-6694/14/14/3298

“Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster”
by Montserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-Martín, Clara Sánchez-Menéndez, María Aranzazú Murciano-Antón, Javier García-Pérez et al.
Cancers 2022, 14(22), 5537; https://doi.org/10.3390/cancers14225537
Available online: https://www.mdpi.com/2072-6694/14/22/5537

“Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy”
by Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S. Griffith, David Ferguson and Jayanth Panyam
Cancers 2022, 14(24), 6091; https://doi.org/10.3390/cancers14246091
Available online: https://www.mdpi.com/2072-6694/14/24/6091

“Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy”
by Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Aikaterini Gkoufa, Elena Solomou, Amalia Anastasopoulou, Eleni Palli, Panagiotis Kouzis, Spyros Bouros, Mihalis Samarkos, Gkikas Magiorkinis et al.
Cancers 2022, 14(15), 3791; https://doi.org/10.3390/cancers14153791
Available online: https://www.mdpi.com/2072-6694/14/15/3791

“Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma”
by Changwu Wu, Yingjuan Duan, Siming Gong, Georg Osterhoff, Sonja Kallendrusch and Nikolas Schopow
Cancers 2022, 14(2), 448; https://doi.org/10.3390/cancers14020448
Available online: https://www.mdpi.com/2072-6694/14/2/448